+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thyroid hormone receptor mutations in cancer



Thyroid hormone receptor mutations in cancer



Molecular and Cellular Endocrinology 213(1): 23-30



The thyroid hormone receptors (TRs) mediate the pleiotropic activities of the thyroid hormone (T3) in growth, development, and differentiation and in maintaining metabolic homeostasis. They are ligand-dependent transcription factors and are members of the steroid hormone/retionic acid receptor superfamily. Two TR genes, alpha and beta, located on human chromosomes 17 and 3, respectively, have been identified. That they are cellular homologs of the retroviral v-erbA oncogene suggests their possible involvement in carcinogenesis. Recent studies showed altered expression of TRs at both the mRNA and protein levels and identified somatic mutations of TRs in several human cancers. Furthermore, male transgenic mice overexpressing v-erbA oncogene develop hepatocellular carcinoma. Importantly, a targeted germline mutation of the TRbeta gene leads to the occurrence of metastatic thyroid carcinoma in homozygous mutant mice. These findings provide evidence to support the critical role of TRs in human cancer.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012693973

Download citation: RISBibTeXText

PMID: 15062571

DOI: 10.1016/j.mce.2003.10.051


Related references

Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis. Journal of Thyroid Research 2011: 361304, 2011

Correlations of language abnormalities with localization of mutations in the beta-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations. Journal of Clinical Endocrinology and Metabolism 75(4): 1039-1045, 1992

Mutations of CpG dinucleotides located in the triiodothyronine -binding domain of the thyroid hormone receptor beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone. Journal of Clinical Investigation 94(2): 607-615, 1994

Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone. Journal of Clinical Investigation 94(2): 607-615, 1994

Nomenclature of thyroid hormone receptor beta-gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, United Kingdom. Journal of Clinical Endocrinology and Metabolism 78(4): 990-993, 1994

Nomenclature of thyroid hormone receptor-beta gene mutations in resistance to thyroid hormone: consensus statement from the First Workshop on Thyroid Hormone Resistance, 10-11th July 1993, Cambridge, UK. European Journal of Endocrinology 130(4): 426-428, 1994

Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone: consensus statement from the first workshop on thyroid hormone resistance, July 10-11th 1993, Cambridge, U.K. Thyroid 4(1): 135-137, 1994

Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone: consensus statement from the First Workshop on Thyroid Hormone Resistance, 10-11 July 1993, Cambridge, UK. Clinical Endocrinology 40(5): 697-700, 1994

Three novel mutations of thyroid hormone receptor beta gene in unrelated patients with resistance to thyroid hormone: two mutations of the same codon (H435L and H435Q) produce separate subtypes of resistance. Journal of Clinical Endocrinology and Metabolism 80(12): 3613-3616, 1995

Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone. First workshop on thyroid hormone resistance, July 10-11, 1993, Cambridge, U.K. Journal of Endocrinological Investigation 17(4): 283-287, 1994

Nomenclature of thyroid hormone receptor beta gene mutations in resistance to thyroid hormone Consensus statement from the First Workshop on Thyroid Hormone Resistance. Clinical Endocrinology 40(5): 697-700, 1994

Search for genetic variants in the retinoid X receptor-gamma-gene by polymerase chain reaction-single-strand conformation polymorphism in patients with resistance to thyroid hormone without mutations in thyroid hormone receptor beta gene. Thyroid 14(5): 355-358, 2004

Three novel mutations at serine 314 in the thyroid hormone beta receptor differentially impair ligand binding in the syndrome of resistance to thyroid hormone. Endocrinology 140(12): 5901-5906, 1999

Three Japanese patients from two families with generalized resistance to thyroid hormone with mutations in exon 9 of the thyroid hormone receptor beta gene. Internal Medicine 40(8): 756-758, 2001